<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>FDA批准首个每月可注射的药物来治疗HIV感染 FDA approves first monthly injectable to treat HIV infection</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">FDA approves first monthly injectable to treat HIV infection<br/>FDA批准首个每月可注射的药物来治疗HIV感染 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-01-28 22:18:29</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/1/84206648421417b7aa857aa9db4b8435.jpg"><img src="http://img2.diglog.com/img/2021/1/84206648421417b7aa857aa9db4b8435.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>In a move that could transform HIV treatment, the Food and Drug Administration has approved a monthly injectable medication, a regimen designed to rival pills that must be taken daily.</p><p>为了改变艾滋病毒的治疗方法，美国食品药品监督管理局（FDA）批准了每月可注射药物的治疗方案，旨在与必须每天服用的药匹敌。</p><p> The newly approved medicine, which is called Cabenuva, represents a significant advance in treating what continues to be a highly infectious disease. In 2018, for instance, there were approximately 36,400 newly infected patients living with HIV in the U.S., according to the Centers for Disease Control and Prevention. About 1.7 million people worldwide became newly infected in 2019, according to UNAIDS.</p><p> 新批准的药物称为卡贝奴娃（Cabenuva），代表了在治疗继续是高度传染性疾病方面的重大进步。根据疾病控制与预防中心的数据，例如，在2018年，美国大约有36,400名新感染HIV的患者。根据联合国艾滋病规划署的数据，2019年全球约有170万人被新感染。</p><p> Although several medicines exist for treating HIV, ViiV Healthcare is banking on the improved convenience of getting a monthly shot, even if it must be administered by a health care provider. The company, which is largely controlled by GlaxoSmithKline ( GSK), gathered data showing nine of 10 patients in pivotal studies claimed to prefer the shot over taking pills each day.</p><p> 尽管存在几种用于治疗HIV的药物，但ViiV Healthcare依靠提高每月打针的便利性，即使必须由医疗保健提供者来管理也是如此。该公司主要由葛兰素史克（GSK）控制，该公司收集的数据显示，在关键研究中，每10名患者中就有9名声称比每天服用药更喜欢注射。</p><p>   “This approval will allow some patients the option of receiving once-monthly injections in lieu of a daily oral treatment regimen,” said John Farley, who heads the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, in a  statement. “Having this treatment available for some patients provides an alternative for managing this chronic condition.”</p><p>   FDA药品评估与研究中心传染病办公室负责人约翰·法利（John Farley）在一份声明中说：“这项批准将使某些患者可以选择每月一次注射来代替每日口服治疗方案。 “为某些患者提供这种治疗方法为控制这种慢性病提供了另一种选择。”</p><p>   Two clinical studies of more than 1,100 patients from 16 countries found that Cabenuva was as effective in suppressing the virus as the daily, oral, three-drug regimens that were taken by patients throughout the 48-week study period. However, patients must first take an oral version of the injectable medicine and another pill for the first month before pivoting to monthly shots, according to the FDA.</p><p>   对来自16个国家/地区的1,100多名患者进行的两项临床研究发现，Cabenuva在抑制病毒方面与在整个48周的研究期间采用的每​​日口服三药疗法一样有效。但是，根据FDA的说法，患者必须在开始服用第一个月的口服药物和另一片药后才开始每月服用。</p><p>   The cost, however, is steep — the list, or wholesale, price is $3,960 a month, or more than $47,500 a year. The list price for the one-time initiation dose is $5,490. However, a ViiV spokeswoman explained that a 30-day oral “lead-in,” which is required as part of the approval, will be made available at no charge to patients. She also maintained the list price for the monthly shot is “within the range” of HIV treatment pills on the market today.</p><p>   但是，成本非常高昂，清单或批发价为每月3,960美元，或每年超过47,500美元。一次性启动剂量的标价为$ 5,490。但是，ViiV的一位发言人解释说，作为批准的一部分，将需要向患者免费提供30天的口服“导入”。她还维持了目前市场上每月注射剂量在“范围内”的艾滋病治疗药的标价。</p><p> There is also considerable competition from Gilead Sciences ( GILD), which markets several HIV medicines. During 2019, its HIV treatment franchise generated $17.2 billion in revenue, a 12.5% year-over-year increase, and grabbed more than 80% of the market for patients starting HIV therapy, according to Cowen analyst Phil Nadeau. He expects HIV medication sales to hit $24.4 billion in 2025, but points to HIV prevention pills as big drivers of that increase.</p><p> 来自吉利德科学公司（GILD）的竞争也很激烈，该公司销售几种HIV药物。据Cowen分析师Phil Nadeau称，在2019年期间，其HIV治疗专营权产生了172亿美元的收入，同比增长12.5％，并抢占了开始进行HIV治疗的患者的80％以上的市场。他预计，到2025年，艾滋病毒药物的销售额将达到244亿美元，但他指出，预防艾滋病毒的药丸是这一增长的主要推动力。 </p><p> ViiV, meanwhile, is developing an every-other-month injectable in hopes of capturing a more substantial market share.</p><p>同时，ViiV正在开发每隔一个月的注射剂，以期争取更大的市场份额。</p><p> Last November, an  interim analysis found cabotegravir – a component of Cabenuva – was 89% more effective in preventing infection among women than Truvada, a Gilead pill that must be taken daily and is the current standard of care. And a separate analysis released in July showed the every-other-month shot protected uninfected people by 66% more compared with Truvada in at-risk men and transgender women who have sex with men.</p><p> 去年11月，一项临时分析发现，卡波替韦是卡贝诺瓦（Cabenuva）的组成部分，在预防女性感染方面比特鲁瓦达（Truvada）疗效高89％，特鲁瓦达是一种吉利德丸，必须每天服用，是目前的护理标准。 7月发布的另一项分析表明，在处于危险中的男性和与男性发生性关系的变性女性中，每隔一个月的枪击对未感染者的保护作用比Truvada高66％。</p><p> “We see Cabenuva as the beginning of long-acting treatment for HIV,” said Kimberly Smith, who heads global research and medical strategy at ViiV, who expects to seek FDA approval for this version of the shot in coming weeks. “We’re opening the door with Cabenuva and will only create more hunger for other long-acting therapies. It really becomes a sort of anchor.”</p><p> ViiV全球研究和医学策略负责人金伯利·史密斯（Kimberly Smith）表示：“我们认为Cabenuva是长效治疗HIV的开始，”他希望在未来几周内寻求FDA批准。 “我们正在打开Cabenuva的大门，只会为其他长效疗法带来更多的饥饿感。它确实成为一种锚。”</p><p> The approval, by the way, comes more than a year after ViiV hoped to win approval for the treatment. In late 2019, the FDA issued a so-called complete response letter and explained approval could not be granted at the time due to issues with chemistry, manufacturing and controls, which are used to determine safety, effectiveness and quality.</p><p> 顺便说一句，批准是在ViiV希望获得该治疗的批准之后一年多的时间。在2019年下半年，FDA发出了所谓的完整答复信，并解释说由于化学，制造和控制方面的问题（当时用于确定安全性，有效性和质量），当时无法批准。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.statnews.com/pharmalot/2021/01/21/fda-hiv-aids-injectable/">https://www.statnews.com/pharmalot/2021/01/21/fda-hiv-aids-injectable/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/药物/">#药物</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/approves/">#approves</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/治疗/">#治疗</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>